HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Owen L Woodman Selected Research

Calcium-Calmodulin-Dependent Protein Kinase Type 2

1/2018Protection against reperfusion injury by 3',4'-dihydroxyflavonol in rat isolated hearts involves inhibition of phospholamban and JNK2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Owen L Woodman Research Topics

Disease

15Reperfusion Injury
01/2018 - 12/2003
8Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 09/2005
8Ischemia
01/2018 - 01/2003
7Inflammation (Inflammations)
04/2024 - 05/2011
6Myocardial Ischemia (Ischemic Heart Diseases)
01/2018 - 03/2008
5Infarction (Infarctions)
07/2015 - 06/2004
4Hypertension (High Blood Pressure)
05/2023 - 01/2007
4Type 2 Diabetes Mellitus (MODY)
01/2023 - 06/2011
4Hyperglycemia
01/2020 - 01/2011
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2019 - 04/2008
3Fibrosis (Cirrhosis)
02/2024 - 01/2011
3Left Ventricular Dysfunction
01/2023 - 01/2011
3Myocardial Infarction
01/2022 - 07/2015
3Stroke (Strokes)
04/2008 - 07/2004
2Cardiomegaly (Heart Hypertrophy)
02/2024 - 07/2010
2Heart Failure
01/2023 - 02/2016
2Diabetes Mellitus
01/2020 - 02/2011
2Myocardial Reperfusion Injury
01/2018 - 01/2017
2Obesity
01/2017 - 01/2016
2Vascular Diseases (Vascular Disease)
01/2016 - 04/2007
2Thrombosis (Thrombus)
05/2014 - 01/2013
2Hypertrophy
01/2011 - 10/2006
1Colitis
04/2024
1Cardiomyopathies (Cardiomyopathy)
01/2023
1Diabetic Cardiomyopathies
01/2023
1Atherosclerotic Plaque (Atheroma)
01/2022
1Body Weight (Weight, Body)
01/2020
1Vascular System Injuries
01/2018
1Cognitive Dysfunction
01/2017
1Memory Disorders (Memory Loss)
01/2017
1Weight Gain
01/2017
1Carotid Artery Thrombosis
05/2014

Drug/Important Bio-Agent (IBA)

13AntioxidantsIBA
01/2019 - 12/2003
123',4'-dihydroxyflavonolIBA
01/2018 - 06/2004
11FlavonolsIBA
01/2018 - 11/2004
73-hydroxyflavoneIBA
01/2022 - 03/2008
6Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2023 - 12/2003
5Superoxides (Superoxide)IBA
01/2020 - 06/2004
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 11/2009
4Vasodilator Agents (Vasodilators)IBA
09/2011 - 11/2004
3Streptozocin (Streptozotocin)FDA Link
01/2023 - 04/2008
3IsoflavonesIBA
04/2012 - 07/2004
2Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
04/2024 - 09/2023
2CollagenIBA
02/2024 - 01/2011
2CalciumIBA
02/2024 - 01/2017
2salicylhydroxamic acid (SHAM)IBA
01/2023 - 01/2020
2Blood Glucose (Blood Sugar)IBA
01/2020 - 06/2015
2Phosphotransferases (Kinase)IBA
01/2018 - 07/2015
2Protein Kinases (Protein Kinase)IBA
01/2018 - 05/2011
2Angiotensin IIIBA
10/2017 - 04/2007
2Hydrogen Sulfide (Sulfide, Hydrogen)IBA
01/2017 - 10/2013
2ProdrugsIBA
07/2015 - 12/2013
2QuercetinIBA
05/2014 - 01/2013
2p38 Mitogen-Activated Protein KinasesIBA
12/2013 - 05/2011
2Glucose (Dextrose)FDA LinkGeneric
03/2013 - 01/2003
2ResveratrolIBA
09/2010 - 01/2007
2EquolIBA
04/2007 - 01/2007
2daidzeinIBA
04/2007 - 07/2004
2Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
01/2006 - 12/2003
1Proteins (Proteins, Gene)FDA Link
02/2024
1ElastinIBA
02/2024
1GlucocorticoidsIBA
02/2024
1Annexin A1IBA
02/2024
1GTP-Binding Proteins (G-Protein)IBA
09/2023
1ProstaglandinsIBA
05/2023
1Sucrose (Saccharose)IBA
01/2023
1LipoxinsIBA
02/2020
1lipoxin A4IBA
02/2020
1nitroxylIBA
01/2020
1LinagliptinIBA
01/2019
1glimepiride (Amarel)FDA LinkGeneric
01/2019
1VildagliptinIBA
01/2019
1Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA
01/2019
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2018
1phospholambanIBA
01/2018
1FlavonesIBA
01/2018
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
10/2017
1TaurineFDA Link
10/2017
1ursodoxicoltaurineIBA
10/2017
1Vasoconstrictor AgentsIBA
10/2017
1SugarsIBA
01/2017
1Mitochondrial Permeability Transition PoreIBA
01/2017
1Dopamine (Intropin)FDA LinkGeneric
01/2017
1IncretinsIBA
01/2017
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2017
1Opioid Analgesics (Opioids)IBA
01/2017
1Adenosine (Adenocard)FDA LinkGeneric
01/2017
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2017
1DobutamineFDA LinkGeneric
02/2016
1oxyhyponitriteIBA
02/2016
1TocominIBA
01/2016
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
07/2015
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2015
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
07/2015
1ferric chlorideIBA
05/2014
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
12/2013

Therapy/Procedure

10Therapeutics
05/2023 - 07/2004
3Drug Therapy (Chemotherapy)
04/2024 - 02/2016
2Thrombolytic Therapy
09/2011 - 11/2004
1Surgical Amputation (Amputations)
01/2022